Distillate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$6.54M |
| 2 |
Micron Technology
MU
|
+$6.22M |
| 3 |
Lam Research
LRCX
|
+$6M |
| 4 |
TJX Companies
TJX
|
+$5.48M |
| 5 |
AbbVie
ABBV
|
+$5.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$6.95M |
| 2 |
Texas Instruments
TXN
|
+$4.73M |
| 3 |
Honeywell
HON
|
+$4.33M |
| 4 |
Aon
AON
|
+$4.16M |
| 5 |
MRSH
Marsh
MRSH
|
+$3.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Industrials | 22.27% |
| 3 | Healthcare | 21.19% |
| 4 | Consumer Discretionary | 13.66% |
| 5 | Consumer Staples | 7.46% |
Similar funds
Distillate Capital Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Distillate Capital Partners held 128 positions worth $596M, up 59% from $376M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Distillate Capital Partners deployed $167M of net new capital in Q4 2021, opening 18 new positions and adding to 89 existing holdings. Its largest new stake was Blackrock: 7,164 shares worth $6.56M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was TFI International, an estimated $57.1K trimmed.
- Distillate Capital Partners's largest Q4 2021 buy was Blackrock: 7,164 shares worth $6.56M.
- Distillate Capital Partners added most to AbbVie in Q4 2021, an estimated $5.19M increase.
- Distillate Capital Partners's biggest Q4 2021 reduction was TFI International, cutting an estimated $57.1K.
- Distillate Capital Partners fully exited Oracle in Q4 2021, selling an estimated $6.95M.
- Distillate Capital Partners's ten largest holdings make up 21% of its $596M portfolio in Q4 2021.
- Distillate Capital Partners opened 18 new positions and closed 20 in Q4 2021.
- Distillate Capital Partners's portfolio value rose 59% quarter-over-quarter to $596M.
Based on Distillate Capital Partners's 13F filing for Q4 2021, filed 8 Feb 2022.